Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity.
about
New perspectives on the role of vitiligo in immune responses to melanomaIdentification of peptides specific for antibodies in vitiligo using a phage library.Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell MobilizationDetection of antigen-specific cytotoxic T lymphocytes: significance for investigative dermatology.Autoimmune melanocyte destruction in vitiligo.Association of Angiotensin-Converting Enzyme (ACE) Gene Polymorphism with Inflammation and Cellular Cytotoxicity in Vitiligo PatientsMammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligoAutoantibodies as diagnostic and predictive markers of vitiligo.The role of T cells in cutaneous autoimmune disease.Therapeutic implications of autoimmune vitiligo T cells.Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.Vitiligo: auto-immunity and immune responses.Rituximab: applications in dermatology.Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?Alopecia totalis and vitiligo in common variable immunodeficiencyNarrow-band UVB irradiation stimulates the migration and functional development of vitiligo-IgG antibodies-treated pigment cells.Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients.Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?Review of the etiopathomechanism of vitiligo: a convergence theory.Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1.Elevated serum antimelanocyte antibody level in cerebriform intradermal nevus with vitiligo.A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo.Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate.Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab.Suplatast tosilate (IPD), a new immunoregulator, is effective in vitiligo treatment.Evaluation of serum immunoglobulins concentrations and distributions in vitiligo patients.Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity.Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo
P2860
Q26996799-5ED98961-541C-43BC-8F94-2A7F43DEE038Q33224361-85BD6F56-C17A-498C-9EB3-6D6CFBD745DCQ33784208-1E8E4531-3660-43F7-B84B-9E90BEC580FFQ34022532-2563AD80-6C30-46BA-A890-B57ABB85877FQ34335855-3215B8E4-E695-451C-A70C-FE2632696C94Q35692379-CE274022-E415-40BD-AAC7-B344F860A11CQ35798261-A84251AD-C729-4DFB-8535-55E4DC8ECD60Q35934690-8835A401-1751-4829-B47F-62064C91CB02Q36277428-8C75D151-4006-40EE-BC9B-ED1B50363A4AQ36292745-A31C047E-E341-4F16-A943-1FDBE7747BB6Q36389114-1185BEAB-15D7-44C5-AC59-96EE2BF0D1E0Q36478782-7F9DB8A8-CD6C-4DCC-B459-C6046F42DE4FQ36623217-5510F8FF-2511-4BBD-A7AB-7468F5BF5D4CQ36958358-8094D8E8-0DEE-480D-AD72-5F7DC74F6850Q38651121-7F4AE214-5538-4370-B74D-41F887E79783Q39547510-5065E455-04B7-4C14-A160-4475AC712477Q40282263-5FE91222-162C-422D-B2BC-E7B9654DCB5AQ40506697-4957A66E-8C2B-4772-811F-6FAA8F4EC0B7Q40742658-80FE1A1F-642C-433D-A8AC-E1D624741006Q44116002-0AB8AFC0-8B3F-4572-B00B-65196FCE46DEQ45113275-B340B121-9E47-4083-9767-0CB2F2E54646Q46599062-C7F966CA-A9CD-45E4-8B82-A2E21663C3C2Q47784094-89DCE99E-6DC5-4BC7-B5E0-C0D28C09C81AQ47860341-1550D6FE-AE17-4B6B-9765-F3E392EE1A74Q48019251-9AA05EAA-DAD1-45C4-963C-E910A3DA2276Q50876213-A22FE8F2-AC52-4741-8D21-7C2EA7C800E2Q53762070-D3740368-DD1E-46D4-9AB7-616024601D8CQ56892977-EA266EDF-8748-476E-8EE7-C3C2E73786E2
P2860
Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Evidence for immunologic mecha ...... pendent cellular cytotoxicity.
@en
type
label
Evidence for immunologic mecha ...... pendent cellular cytotoxicity.
@en
prefLabel
Evidence for immunologic mecha ...... pendent cellular cytotoxicity.
@en
P2093
P1476
Evidence for immunologic mecha ...... pendent cellular cytotoxicity.
@en
P2093
Bystryn JC
Kissinger RM
Naughton GM
P2888
P304
P356
10.1111/1523-1747.EP12461505
P407
P577
1988-06-01T00:00:00Z
P5875
P6179
1024362642